Delivery Order SPE2DB20D7066-SPE2DB26FC1MZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $39,474.69 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits on October 16, 2025, with completion scheduled for October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,334.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TNKASE 50 MG Kits with an ultimate completion date of September 2, 2025. This competitive award, issued on August 29, 2025, carries no set-aside designation and represents a child contract under the prime vendor framework. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,476.17 for TNKASE 50 MG kits on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $30,570.33 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits under a firm fixed-price contract. This non-set-aside award was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,877.34 to AmerisourceBergen Drug Corp for TNKASE 50 mg kits, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,548.03 for TNKASE 50 mg kits on June 19, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is funded by the Defense Logistics Agency's Medical Supply Chain division. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- This is a $28,268.46 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4565924196 TNKASE 50 MG KITS. The delivery order has a completion date of September 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,327.64, is for the delivery of 4565320280 TNKASE 50 MG KITS and has an ultimate completion date of August 2, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,055.36 in Tankase 50 mg kits under a firm fixed-price contract, with final completion scheduled for October 31, 2025. This non-set-aside award was issued on October 30, 2025, and the products will be delivered to the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,600,934 units of TNKASE 50 MG KITS, a pharmaceutical product, with a ceiling value of $10,093.08. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1MZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,773.14 to supply 50 mg TNKASE kits to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The award, issued on October 31, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of November 3, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for federal agencies through its comprehensive pharmaceutical portfolio. The company's DLA prime contract vehicle supports military healthcare programs worldwide and encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order is one of numerous acquisitions the company executes through its DLA relationship, demonstrating its established capability as a preferred vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 10/31/25 |